Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 36 entries
Sorted by: Best Match Show Resources per page
[Professor Kalman Kiraly (1919-1978)].

Annales de dermatologie et de venereologie

Thivolet J.
PMID: 384876
Ann Dermatol Venereol. 1979 Jan;106(1):94-5.

No abstract available.

Cite
Thivolet J. Professeur Kalman Kiraly (1919-1978). [Professor Kalman Kiraly (1919-1978)]. Ann Dermatol Venereol. 1979;106(1):94-5
Thivolet, J. (1979). Professeur Kalman Kiraly (1919-1978). [Professor Kalman Kiraly (1919-1978)]. Annales de dermatologie et de venereologie, 106(1), 94-5.
Thivolet, J. "Professeur Kalman Kiraly (1919-1978)." [Professor Kalman Kiraly (1919-1978)]. Annales de dermatologie et de venereologie vol. 106,1 (1979): 94-5.
Thivolet J. Professeur Kalman Kiraly (1919-1978). [Professor Kalman Kiraly (1919-1978)]. Ann Dermatol Venereol. 1979 Jan;106(1):94-5. French. PMID: 384876.
Copy Download .nbib Format: NLM
[Insulin-dependent diabetes. Epidemiology, etiology, physiopathology, diagnosis, development, prognosis and therapeutic principles].

La Revue du praticien

Thivolet C, Tourniaire J.
PMID: 1784911
Rev Prat. 1991 Oct 01;41(21):2123-31.

No abstract available.

Cite
Thivolet C, Tourniaire J. Diabète insulinodépendant. Epidémiologie, étiologie, physiopathologie, diagnostic, évolution, pronostic et principes thérapeutiques. [Insulin-dependent diabetes. Epidemiology, etiology, physiopathology, diagnosis, development, prognosis and therapeutic principles]. Rev Prat. 1991;41(21):2123-31
Thivolet, C., & Tourniaire, J. (1991). Diabète insulinodépendant. Epidémiologie, étiologie, physiopathologie, diagnostic, évolution, pronostic et principes thérapeutiques. [Insulin-dependent diabetes. Epidemiology, etiology, physiopathology, diagnosis, development, prognosis and therapeutic principles]. La Revue du praticien, 41(21), 2123-31.
Thivolet, C, and Tourniaire, J. "Diabète insulinodépendant. Epidémiologie, étiologie, physiopathologie, diagnostic, évolution, pronostic et principes thérapeutiques." [Insulin-dependent diabetes. Epidemiology, etiology, physiopathology, diagnosis, development, prognosis and therapeutic principles]. La Revue du praticien vol. 41,21 (1991): 2123-31.
Thivolet C, Tourniaire J. Diabète insulinodépendant. Epidémiologie, étiologie, physiopathologie, diagnostic, évolution, pronostic et principes thérapeutiques. [Insulin-dependent diabetes. Epidemiology, etiology, physiopathology, diagnosis, development, prognosis and therapeutic principles]. Rev Prat. 1991 Oct 01;41(21):2123-31. French. PMID: 1784911.
Copy Download .nbib Format: NLM
Health Technology Assessments In Oncology: Crizotinib Case Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Thivolet M, Kornfeld A, Toumi M.
PMID: 27202404
Value Health. 2014 Nov;17(7):A661. doi: 10.1016/j.jval.2014.08.2424. Epub 2014 Oct 26.

No abstract available.

Cite
Thivolet M, Kornfeld A, Toumi M. Health Technology Assessments In Oncology: Crizotinib Case Study. Value Health. 2014;17(7):A661doi: 10.1016/j.jval.2014.08.2424.
Thivolet, M., Kornfeld, A., & Toumi, M. (2014). Health Technology Assessments In Oncology: Crizotinib Case Study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A661. https://doi.org/10.1016/j.jval.2014.08.2424
Thivolet, M, et al. "Health Technology Assessments In Oncology: Crizotinib Case Study." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A661. doi: https://doi.org/10.1016/j.jval.2014.08.2424
Thivolet M, Kornfeld A, Toumi M. Health Technology Assessments In Oncology: Crizotinib Case Study. Value Health. 2014 Nov;17(7):A661. doi: 10.1016/j.jval.2014.08.2424. Epub 2014 Oct 26. PMID: 27202404.
Copy Download .nbib Format: NLM
Stefanie jablonska, the iron lady of warsaw.

European journal of dermatology : EJD

Thivolet J.
PMID: 10586139
Eur J Dermatol. 1999 Dec;9(8):664.

Among the founders of immuno-dermatology, a prominent place is occupied by Stefanie Jablonska, Professor of Dermatology in Warsaw. Despite all the difficulties which her country has known, she has been able to work, train many students, travel the whole...

Cite
Thivolet J. Stefanie jablonska, the iron lady of warsaw. Eur J Dermatol. 1999;9(8):664
Thivolet, J. (1999). Stefanie jablonska, the iron lady of warsaw. European journal of dermatology : EJD, 9(8), 664.
Thivolet. "Stefanie jablonska, the iron lady of warsaw." European journal of dermatology : EJD vol. 9,8 (1999): 664.
Thivolet J. Stefanie jablonska, the iron lady of warsaw. Eur J Dermatol. 1999 Dec;9(8):664. PMID: 10586139.
Copy Download .nbib Format: NLM
Editorial 2005.

European journal of dermatology : EJD

Thivolet J.
PMID: 15701585
Eur J Dermatol. 2005 Jan-Feb;15(1):3.

No abstract available.

Cite
Thivolet J. Editorial 2005. Eur J Dermatol. 2005;15(1):3
Thivolet, J. (2005). Editorial 2005. European journal of dermatology : EJD, 15(1), 3.
Thivolet, Jean. "Editorial 2005." European journal of dermatology : EJD vol. 15,1 (2005): 3.
Thivolet J. Editorial 2005. Eur J Dermatol. 2005 Jan-Feb;15(1):3. PMID: 15701585.
Copy Download .nbib Format: NLM
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Diabetes & metabolism

Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E.
PMID: 34813929
Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21.

Type 1 diabetes mellitus (T1DM) is associated with a high risk of cardiovascular (CV) complications, even after controlling for traditional CV risk factors. Therefore, determinants of the residual increased CV morbidity and mortality remain to be discovered. This prospective...

Cite
Riveline JP, Vergés B, Detournay B, et al. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021;48(3):101306doi: 10.1016/j.diabet.2021.101306.
Riveline, J. P., Vergés, B., Detournay, B., Picard, S., Benhamou, P. Y., Bismuth, E., Bordier, L., Jeandidier, N., Joubert, M., Roussel, R., Sola-Gazagnes, A., Bonnefond, A., Clavel, S., Velayoudom, F. L., Beltrand, J., Hanaire, H., Fontaine, P., Thivolet, C., Servy, H., Tubiana, S., Lion, S., Gautier, J. F., Larger, E., Vicaut, E., Sablone, L., Fagherazzi, G., & Cosson, E. (2021). Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes & metabolism, 48(3), 101306. https://doi.org/10.1016/j.diabet.2021.101306
Riveline, J P, et al. "Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study." Diabetes & metabolism vol. 48,3 (2021): 101306. doi: https://doi.org/10.1016/j.diabet.2021.101306
Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21. PMID: 34813929.
Copy Download .nbib Format: NLM
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations.

Diabetes & metabolism

Thivolet C.
PMID: 34673241
Diabetes Metab. 2021 Nov;47(6):101290. doi: 10.1016/j.diabet.2021.101290. Epub 2021 Oct 18.

No abstract available.

Cite
Thivolet C. Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations. Diabetes Metab. 2021;47(6):101290doi: 10.1016/j.diabet.2021.101290.
Thivolet, C. (2021). Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations. Diabetes & metabolism, 47(6), 101290. https://doi.org/10.1016/j.diabet.2021.101290
Thivolet, Charles. "Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations." Diabetes & metabolism vol. 47,6 (2021): 101290. doi: https://doi.org/10.1016/j.diabet.2021.101290
Thivolet C. Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations. Diabetes Metab. 2021 Nov;47(6):101290. doi: 10.1016/j.diabet.2021.101290. Epub 2021 Oct 18. PMID: 34673241; PMCID: PMC8523025.
Copy Download .nbib Format: NLM
Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox.

Seminars in interventional radiology

Mastier C, Gjorgjievska A, Thivolet A, Bouhamama A, Cuinet M, Pilleul F, Tselikas L, de Baère T, Deschamps F.
PMID: 30402011
Semin Intervent Radiol. 2018 Oct;35(4):281-289. doi: 10.1055/s-0038-1673420. Epub 2018 Nov 05.

The prevalence of patients with painful bone metastases is constantly increasing. This is related to the rising incidence of cancer and increasing life expectancy of patients with metastatic stage. Advances in imaging and development of percutaneous techniques have gradually...

Cite
Mastier C, Gjorgjievska A, Thivolet A, et al. Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox. Semin Intervent Radiol. 2018;35(4):281-289doi: 10.1055/s-0038-1673420.
Mastier, C., Gjorgjievska, A., Thivolet, A., Bouhamama, A., Cuinet, M., Pilleul, F., Tselikas, L., de Baère, T., & Deschamps, F. (2018). Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox. Seminars in interventional radiology, 35(4), 281-289. https://doi.org/10.1055/s-0038-1673420
Mastier, Charles, et al. "Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox." Seminars in interventional radiology vol. 35,4 (2018): 281-289. doi: https://doi.org/10.1055/s-0038-1673420
Mastier C, Gjorgjievska A, Thivolet A, Bouhamama A, Cuinet M, Pilleul F, Tselikas L, de Baère T, Deschamps F. Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox. Semin Intervent Radiol. 2018 Oct;35(4):281-289. doi: 10.1055/s-0038-1673420. Epub 2018 Nov 05. PMID: 30402011; PMCID: PMC6218260.
Copy Download .nbib Format: NLM
[Type 1 diabetes: 10 key messages].

La Revue du praticien

Thivolet C.
PMID: 30869252
Rev Prat. 2018 Jun;68(6):632.

No abstract available.

Cite
Thivolet C. Diabète de type 1 : les 10 points clés. [Type 1 diabetes: 10 key messages]. Rev Prat. 2018;68(6):632
Thivolet, C. (2018). Diabète de type 1 : les 10 points clés. [Type 1 diabetes: 10 key messages]. La Revue du praticien, 68(6), 632.
Thivolet, Charles. "Diabète de type 1 : les 10 points clés." [Type 1 diabetes: 10 key messages]. La Revue du praticien vol. 68,6 (2018): 632.
Thivolet C. Diabète de type 1 : les 10 points clés. [Type 1 diabetes: 10 key messages]. Rev Prat. 2018 Jun;68(6):632. French. PMID: 30869252.
Copy Download .nbib Format: NLM
Comment on Jackson et al. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus. Diabetes Care 2017;40:723-725.

Diabetes care

Marchand L, Garnier L, Fabien N, Thivolet C.
PMID: 28931712
Diabetes Care. 2017 Oct;40(10):e155. doi: 10.2337/dc17-1044.

No abstract available.

Cite
Marchand L, Garnier L, Fabien N, et al. Comment on Jackson et al. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus. Diabetes Care 2017;40:723-725. Diabetes Care. 2017;40(10):e155doi: 10.2337/dc17-1044.
Marchand, L., Garnier, L., Fabien, N., & Thivolet, C. (2017). Comment on Jackson et al. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus. Diabetes Care 2017;40:723-725. Diabetes care, 40(10), e155. https://doi.org/10.2337/dc17-1044
Marchand, Lucien, et al. "Comment on Jackson et al. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus. Diabetes Care 2017;40:723-725." Diabetes care vol. 40,10 (2017): e155. doi: https://doi.org/10.2337/dc17-1044
Marchand L, Garnier L, Fabien N, Thivolet C. Comment on Jackson et al. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus. Diabetes Care 2017;40:723-725. Diabetes Care. 2017 Oct;40(10):e155. doi: 10.2337/dc17-1044. PMID: 28931712.
Copy Download .nbib Format: NLM
Time Limits Restriction in Germany.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Thivolet M, Soussi I, Kornfeld A, Toumi M.
PMID: 27201124
Value Health. 2014 Nov;17(7):A431. doi: 10.1016/j.jval.2014.08.1096. Epub 2014 Oct 26.

No abstract available.

Cite
Thivolet M, Soussi I, Kornfeld A, et al. Time Limits Restriction in Germany. Value Health. 2014;17(7):A431doi: 10.1016/j.jval.2014.08.1096.
Thivolet, M., Soussi, I., Kornfeld, A., & Toumi, M. (2014). Time Limits Restriction in Germany. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A431. https://doi.org/10.1016/j.jval.2014.08.1096
Thivolet, M, et al. "Time Limits Restriction in Germany." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A431. doi: https://doi.org/10.1016/j.jval.2014.08.1096
Thivolet M, Soussi I, Kornfeld A, Toumi M. Time Limits Restriction in Germany. Value Health. 2014 Nov;17(7):A431. doi: 10.1016/j.jval.2014.08.1096. Epub 2014 Oct 26. PMID: 27201124.
Copy Download .nbib Format: NLM
Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis.

Journal of molecular biomarkers & diagnosis

Villard A, Marchand L, Thivolet C, Rome S.
PMID: 27308097
J Mol Biomark Diagn. 2015 Nov;6(6). doi: 10.4172/2155-9929.1000251. Epub 2015 Oct 02.

Type 2 diabetes mellitus (T2DM) is the most common metabolic disorder worldwide. Because of population aging and increasing trends toward obesity and sedentary lifestyles, the number of affected individuals is increasing at worrisome rates. While both environmental and genetic...

Cite
Villard A, Marchand L, Thivolet C, et al. Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis. J Mol Biomark Diagn. 2015;6(6)doi: 10.4172/2155-9929.1000251.
Villard, A., Marchand, L., Thivolet, C., & Rome, S. (2015). Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis. Journal of molecular biomarkers & diagnosis, 6(6), . https://doi.org/10.4172/2155-9929.1000251
Villard, Audrey, et al. "Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis." Journal of molecular biomarkers & diagnosis vol. 6,6 (2015). doi: https://doi.org/10.4172/2155-9929.1000251
Villard A, Marchand L, Thivolet C, Rome S. Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis. J Mol Biomark Diagn. 2015 Nov;6(6). doi: 10.4172/2155-9929.1000251. Epub 2015 Oct 02. PMID: 27308097; PMCID: PMC4905583.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 36 entries